Application 212801

Type
NDA
Sponsor
RECORDATI RARE

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001ISTURISAOSILODROSTAT PHOSPHATETABLET;ORALEQ 1MG BASEYesNo
002ISTURISAOSILODROSTAT PHOSPHATETABLET;ORALEQ 5MG BASEYesNo
003ISTURISAOSILODROSTAT PHOSPHATETABLET;ORALEQ 10MG BASEYesYes

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
55292-320IsturisaOsilodrostatRecordati Rare Diseases, Inc.NDACurrent
55292-320IsturisaOsilodrostatRecordati Rare Diseases, Inc.NDACurrent
55292-321IsturisaOsilodrostatRecordati Rare Diseases, Inc.NDACurrent
55292-321IsturisaOsilodrostatRecordati Rare Diseases, Inc.NDACurrent
55292-322IsturisaOsilodrostatRecordati Rare Diseases, Inc.NDACurrent
55292-322IsturisaOsilodrostatRecordati Rare Diseases, Inc.NDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
84073SUPPL 2025-11-05
84072SUPPL 2025-11-05
82752SUPPL 2025-07-08
82743SUPPL 2025-07-08
82004SUPPL 2025-04-25
81934SUPPL 2025-04-21
62442ORIG2020-04-06
62102ORIG2020-03-10
62085ORIG2020-03-09